DR. STEPHANIE L. GRAFF, director of breast oncology at Lifespan Cancer Institute, was recently named Woman Disruptor of the Year by Healio, a clinical information website, and will help lead the next Destiny Breast clinical trials at Lifespan Corp. / COURTESY LIFESPAN CORP.
Dr. Stephanie L. Graff, director of breast oncology at Lifespan Cancer Institute, was named Woman Disruptor of the Year during the 2022 American Society of Clinical Oncology conference in June. The honor, presented by Healio, a medical industry information website, is a highlight for Graff as she prepares to lead the next phases of the…
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
